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Effects of fibrinogen degradation products on glomerular mesangial
cells in culture. We investigated effects of fibrin, fibrinogen, and
fibrinogen degradation products (FDPs) on human glomerular mesan-
gial cells in culture, using the methods of cell count, 3[H] thymidine
uptake and 51Cr release. Incorporation of 3[Hj thymidine by the cells
was much the same with various concentrations of fibrin and similar to
findings in the control without fibrin. Fibrinogen, FDP-D, -E, low
molecular weight FDP (LMWFDP) fractions I and 3 had no promoting
effects on mesangial cell proliferation. The LMWFDP fraction 2
showed a suppressive effect on the proliferation of cultured cells and
increase of 51Cr release from the cells. The cytotoxic effect of this
fraction was dose-dependent. These results suggest that while fibrin
deposition in the renal glomeruli does not relate with mesangial
hypercellularity, this deposition plays a role in mesangiolysis, through
the production of FDPs.
Effets des produits de degradation du fibrinogène sur des cellules
mésangiales glomerulaires en culture. Nous avons étudië les effets de Ia
fibrine, du fibrinogene et des produits de degradation du fibrinogene
(FDP5) sur des cellules mesangiales glomerulaires humaines en culture,
en utilisant des méthodes de numeration cellulaire, de captation de 3[H]
thymidine et de relargage de 51Cr. L'incorporation de 3[HJ thymidine
par les cellules étaient trés voisine avec diverses concentrations de
fibrine et identique aux résultats du contrôle sans fibrine. Le
fibrinogéne, le FDP-D, -E, les fractions 1 et 3 du FDP de faible poids
modéculaire (LMWFDP) n'avaient pas d'effets promoteurs de la
proliferation cellulaire mésangiale. La fraction 2 du LMWFDP
présentait un effet suppresseur sur Ia proliferation des cellules en
culture et sur l'augmentation du relargage du Cr a partir de ces
cellules. L'effet cytotoxique de cette fraction était dose-dependant. Ces
résultats suggerent que bien que le dépôt de fibrine dans les glomerules
rénaux ne soit pas relié a l'hypercellularité mésangiale, ce depôtjoue un
role dans la mésangiolyse par l'intermédiaire de la production de FDPs.
Fibrin, fibrinogen, and FDPs have various biological activi-
ties. Ishida and Tanaka [1] reported that fibrin had an enhancing
effect on the proliferation of smooth muscle cells in culture.
Hatzfeld, Hatzfeld, and Maigne described that fibrinogen and
its fragment D stimulated proliferation of human hemopoietic
cells in vitro [21. Low molecular weight fibrinogen degradation
products (LMWFDPs) have a number of biological activities
which include: inhibitory effects on platelet aggregation [31 and
blood coagulation [4], chemotaxis for neutrophils [5], enhance-
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ment of vascular permeability [61, and cytotoxic effect on
cultured endothelial cells [7, 81.
The blood coagulation system contributes significantly to
renal damage in various diseases of the kidney. In crescentic
glomerulonephritis, fibrin deposition plays a central role in the
development of extracapillary proliferation [9, 10]. Fibrinogen-
reactive materials may also be found in glomerular tufts under
certain conditions, such as acute glomerulonephritis. The path-
ogenetic significance of this material is unknown.
Krakower and Greenspon [11] isolated renal glomeruli in
1951 and investigations have been done on the biological
properties of isolated glomeruli [12, 13] and cultured glomerular
cells [14—21]. We attempted to determine the effects of fibrin,
fibrinogen, and FDPs on cultured mesangial cells.
Methods
Culture of human glomerular mesangial cells
Fresh kidneys were obtained at autopsy or at the time of
resection for surgical treatment of carcinoma of the renal pelvis
or hypernephroma. The tissue samples were processed under
sterile conditions by a modification of the methods of Foidart et
al [221 and Scheinman and Fish [23]. The renal capsules were
removed and cortices were dissected away from the medulla.
The cortical segments were finely minced into 1 to 2 mm
fragments and incubated with 0.2% collagenase (Sigma Chemi-
cal Co., St. Louis, Missouri) for 20 mm at 37°C. This suspen-
sion was then poured through a stainless steel screen of
60-mesh (pore size, 250 /sm) and then through a 200-mesh (pore
size, 75 pm). The glomeruli and few tubular fragments retained
on the 200-mesh were treated with 0.1% trypsin and 0.02%
EDTA in phosphate-buffered saline for 10 mm at 37°C. After
enzymatic digestion, the suspension was pipetted gently to
remove Bowman's capsules and visceral epithelial cells, and
poured through a 200-mesh on which the glomeruli were re-
tained. The purity of each glomerular preparation was evalu-
ated by phase contrast microscopy and by counting glomeruli.
Preparations that contained more than 95% glomeruli were
used. Isolated glomeruli were cultured in RPMI 1640 medium
(GIBCO, New York, USA) supplemented with 10% fetal calf
serum (GIBCO), penicillin 100 U/ml and streptomycin 100
Lg/ml. The tissue was transferred to culture dishes (Falcon
3001) and incubated in an atmosphere of humidified air contain-
ing 5% CO2. After about 3 weeks, the cells growing out around
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Fig. 1. Separation of LMWFDPs on Sephadex G-25 column chroma-
tography. Three fractions (1, 2, and 3) were obtained.
the attached giomeruli were passed through a 200-mesh and
subcuitured using 0.1% trypsin and 0.02% EDTA. Fourth
passages were used in the experiments. For the serum-free
control medium, RPMI 1640 medium was supplemented with
insulin (NOVO Industry A/S, Denmark) 0.15 U/mi, transferin
(Sigma Chemical Co.) 1 g/ml, selenate Na (Wako, Japan) 1.25
x 10-8 M, and monoethanolamine (Wako, Japan) 75 M.
Purification of fibrinogen, FDP-D, -E, and LMWFDPs
Fibrinogen. Citrated human plasma was absorbed by the
addition of solid BaC12. The Cohn fraction I was obtained by the
addition of 50% ethanol to a final concentration of 8% (v/v) at
—2°C and 0.055 M Na-citrate buffer pH 6, containing 1 M
glycine, 6.5% ethanol [24]. These procedures were repeated
three more times. The fibrinogen finally extracted was dissolved
in a small amount of 0.01 M phosphate buffer pH 7.0 and
lyophilized. Clottability was 96%.
FDP-D and -E. After digesting fibrinogen solution with
human urokinase (0.6 U/mg fibrinogen, The Green Cross Co.,
Tokyo, Japan) for 24 hr, the digests were used for Sephacryl
S-300 column chromatography and Pevicon C-870 block
electrophoresis [25]. FDP-D and -E fractions were concentrated
by PM 10 filter (Amikon, Lexington, Massachusetts) and dia-
lyzed against serum-free RPMI 1640. Identification of these
fragments of fibrinogen was made by 7.0% polyacrylamide gel
electrophoresis in 0.1% sodium dodecyl sulfate and immuno-
electrophoresis analyses using antihuman fibrinogen, antihu-
man FDP-D, and human FDP-E rabbit sera (Behringwerke AG,
Marburg, Germany).
LMWFDPs. Dialysable LMWFDPs were obtained by ultra-
filtration of 24-hr urokinase digests of fibrinogen with PM 10.
The effusate with a molecular weight of less than 10,000 was
chromatographed on a Sephadex G-25 column equilibrated with
0.1 M ammonium acetate pH 7.4 [7]. The first, second, and third
peaks were separated and lyophilized (Fig. 1). Protein concen-
tration was determined by the method of Lowry et al [261.
Morphologic confirmation
The glomerular cells were grown on Tissue-Tek chamber
slides (Miles, Illinois) fixed with 10% formalin, and stained with
toluidine blue. For the demonstration of actin filaments with
heavy meromyosin, cultured glomerular cells were washed with
phosphate buffer containing 2 mrvi MgC12 and 0.1 M NaC1 pH 7.0
(buffer A) and treated with 0.1 mg/ml saponin (Sigma Chemical
Co.) for 20 mm at room temperature in order to permit heavy
meromyosin to diffuse into the cells. After washing with buffer
A, the cells were treated with 2 mg/ml heavy rneromyosin
(presented by Professor I. Ohtusuki, Department of Clinical
Pharmacology, Kyusha University, Fukuoka, Japan [27]) and I
mM disopropyl fluorophosphate in buffer A for 6 hr at 2°C and
washed with buffer A. These cells were fixed in 3% glu-
taraldehyde, postfixed in 1% osmic acid, stained with 0.5%
uranyl acetate, dehydrated in alcohol, and embedded in Epon.
Ultrathin sections were cut, stained with uranyl acetate and
lead citrate, and examined with an electron microscope (JEM-
100, Japan).
To test fibroblast contamination, the cells were cultured in
Eagle's minimum essential medium containing D-valine substi-
tuted for L-valine (GIBCO) and dialyzed fetal calf serum [28].
The cultured glomerular cells were tested for their ability to
grow in RPMI 1640 containing 50 .rg/ml aminonucleoside of
puromycin (Sigma Chemical Co.) [29].
Measurement of cell growth
The proliferative effect of fibrin on cultured glomerular cells
was examined by uptake of 3[H] thymidine by the cells growing
on fibrin-collagen plates. Purified fibrinogen was dissolved in
control medium to yield a final concentration of 0.6, 3, and 15
mg/mi; 0.1 ml of fibrinogen solution was poured into tissue
culture dishes and 0.2 ml of type IV collagen (10 g/ml,
Calbiochem-Behring Co., La Jolla, California) was added. After
shaking, 0.05 ml of thrombin (10 U/ml, Mochida Pharmaceutical
Co., Tokyo, Japan) was poured into the dishes and agitated
gently. The dishes were treated with 0.01 ml of 1 N NaOH and
left to stand for 1 hr for gelation of the collagen [301. One hour
later, each dish was washed three times with control medium
for 16 hr; 3 X l0 cells suspended in control medium were
seeded on the fibrin-collagen coated dishes and 10 pA of 3[H]
thymidine (0.2 mCi/mi, 5.0 Ci/mmoie, RCC Amersham) were
immediately added. These dishes were incubated at 37°C in an
atmosphere of 95% air and 5% CO2. Most cells (70% to 80%)
attached to the fibrin-collagen coated dishes as well as the
collagen coated dishes. After incubation for 1, 2, 4, and 6 days,
respectively, triplicated dishes were drained of the medium and
the cells were harvested by trypsinization. The acid-soluble
fraction was collected and the radioactive DNA was measured
with a liquid scintillation counter (Aloka, LSC-903), according
to the method of Watson and Yamazaki [31]. Control studies
were performed using collagen coated plates and in the absence
of fibrin.
The effects of fibrinogen, FDPs, thrombin, and urokinase
were examined by direct cell count. Equal numbers (5 x l0)
were seeded in tissue culture dishes (Falcon 3001) and in-
cubated with control medium containing those agents. After 1,
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FIg. 2. Morphology of mesangial cells in fourth passages. A round
nodule, which represents an aggregate of cultured cells, is present.
(Toluidine blue, x 25)
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Fig. 4. Effect of fibrin on the incorporation of 3H thymidine into
glomerular mesangial cells in culture. Data are the mean SEM of
triplicate culture.
Fig. 3. (A) Heavy meromyosin-treated electron microscopy of mesan-
gial cells in fourth passages. Abundant thick bundles of microfilaments
(arrow) are located in the periphery of the cytoplasm. The arrowhead
refers to the plasma membrane; N, nucleus (x 4600). (B) An area of
A(b) under higher magnification. Arrowhead appearance is seen along
the microfilaments (series of dots). (x 48,000)
2, 3, 4, 6, and 8 days, the cells were counted in a hemo-
cytometer.
Cytotoxic effects offibrinogen and FDPs measured by 51Cr
release
Confluent glomerular cells cultured in Falcon 3047 dishes
(24-well plates) were incubated with Nal 51CrIO4 (spec act 3.0
GBq/mg Cr, JRIA) in control medium containing 5 /LCi/well for
24 hr. Each well was then washed three times with phosphate
buffered saline and 0.5 ml of control medium containing various
amounts of fibrinogen and FDP fractions were added. After 24
hr of incubation, 0.3 ml of the medium was collected and the
51Cr radioactivity was assayed in a gamma counter (I). Sponta-
neous release of 51Cr (II) was measured using the well contain-
ing the control medium only, and maximum release of 51Cr (III)
was measured using the well which had been frozen and thawed
three times [7]. 5lCr release (%) was calculated as
I — II
x 100 (%)
III — I
Results
Glomerular mesangial cells in culture
Four or 5 days after initiation of the culture, 15 to 30% of the
glomeruli became attached to the bottom of the dish, and we
observed the cells creeping out from the glomeruli. Morphologi-
cally, the cells appeared homogeneous and were characterized
by a stellate or fusiform shape, and by growth in tightly
interwoven bundles. Monolayers of large polygonal epithelial
cells and a cobblestonelike appearance of endothelial cells were
not evident with phase contrast microscopy (Fig. 2).
The mesangial cells contained thick, most often peripherally
located, bundles of microfilaments. In the case of heavy
meromyosin treatment, these filaments showed an arrowhead
appearance characteristic of actin filaments (Fig. 3).
Cell growth was easily maintained in a medium containing
D-valine substituted for L-valine, thereby indicating that the
cells were not fibroblasts. As the aminonucleoside of
puromycin was not cytotoxic toward these cells, the cells were
not epithelial tissues.
714 Tsumagari and Tanaka
CC
E
C.)
C0
00.
0UC
5)C
-o
E
>.
-cI
4.0 r-
3.0 F
-. Control
Fibrin, 5.0mg ml
'- Fibrin, 1.0mg ml
Fibrin, 0.2mg ml
2.0 L
C
0 1 2 4 6
Time, days in culture Time, days in culture
Fig. 5. (A) Effects offibrinogen (A— —A), FDP-D (o o), and FDP-E (—- —) on the growth of glomerular mesangial cells in culture; (.—
—), the control group. (B) Effects of LMWFDPs, urokinase, and thrombin. Symbols are: LMWFDP-l (— - —is); LMWFDP-2
(o n); LMWFDP-3 (A— —A); urokinase (.— - —s); thrombin (0 a); control (. .). Triplicated cultures were counted on each
experimental day. Each point represents the mean SEM.
Effects of fibrin on mesangial cell proliferation
Figure 4 showed the growth patterns of mesangial cells
proliferating on the collagen plate containing 0, 0.2, 1.0, and 5.0
mg/ml fibrin. Incorporation of 3[H] thymidine by the cells was
the same level with various concentrations of fibrin. Enhancing
and/or cytotoxic effects were nil.
Effects of fibrinogen, FDPs, thrombin, and urokinase on
mesangial cell proliferation
The effects of fibrinogen, FDP-D, and -E added to the control
medium were compared with the findings with control media
alone. There was no promoting effect on mesangial cell prolif-
eration (Fig. 5A). The effects of LMWFDPs on cell proliferation
are shown in Figure SB. The LMWFDP fraction 2 showed a
suppressive effect on cell proliferation as compared to the
control media. Other fractions had neither promoting nor sup-
pressive effects on cell growth.
Mesangial cell injuries by fibrinogen and FDPs measured by
51Cr release
Table 1 shows the cytotoxic effects of fibrinogen and FDPs on
cultured mesangial cells. Fibrinogen, LMWFDP fraction 1 and
fraction 3 showed no significant increase of 51Cr release from
mesangial cells. FDP-D and -E had mild cytotoxic properties
and the LMWFDP fraction 2 moderate cytotoxic effects in a
Table 1. Effects of fibrinogen and FDPs on 51Cr release from
glomerular mesangial cells in culturea
Maximum release 100 4.7
Spontaneous release 0 0.9
Fibrinogen, 2 mg/mI —0.2 0.5
FDP-D, 100 ag/ml 6.4 l.9b
FDP-E, 100 jig/mi 6.5 07b
LMWFDP-l, 10 pg/mi 1.9 3.8
LMWFDP-2, 10 pg/mi 16.2 5•7c
LMWFDP-3, 10 isg/ml 3.5 2.3
Thrombin, I U/mi 0.5 1.1
Urokinase, 5 U/mI 4.1 4.3
Each value represents the mean percent SEM of six replicate wells.
bp < 0.01, 'P < 0.005 (compared to spontaneous release).
concentration of 10 jsg/ml. The dose dependency of the
cytotoxic effects of FDP-D, -E, and LMWFDP fraction 2 is
shown in Figure 6. There was an increase in 51Cr release with
increasing concentration of the LMWFDP fraction 2. FDP-D
and -E had no dose-dependent cytotoxic effects on the mesan-
gial cells in culture.
Discussion
Morphological findings in phase contrast microscopy [32—351
and response to aminonucleoside of puromycin [29] or the
medium containing D-valine [28, 29] indicate that cultured
glomerular cells are mesangial in origin.
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Heavy meromyosin specifically binds to actin filaments and a
distinctive arrowhead arrangement, visible in the electron mi-
croscopy, is formed along the actin filaments [361. Heavy
meromyosin has never been found to bind with microtubules,
neurofilaments, intermediate filaments or tonofilaments, thus
the binding to a filament is considered to be a distinctive
histochemical test for the identification of actin. In our observa-
tion, cultured glomerular cells had peripherally located thick
bundles of microfilaments and these filaments showed an arrow-
head appearance with heavy meromyosin treatment. Therefore,
these cells were mesangial in origin.
Fibrin or fibrinogen did not have a promoting effect on
proliferation of mesangial cells in culture. In recent studies, the
glomerular mesangium was found to contain at least two
subpopulations of cells [37, 381. The first is classical mesangial
cells of renal origin and resembling smooth muscle cells, and
the second is Ia-antigen bearing monocytelike cells. The Ia-
antigen bearing cells are present at the frequency of 1 to 2% of
total glomerular cell population in vivo and in the primary
culture, and disappear with prolonged culture. In the acute
stage of glomerulonephritis, monocytes play an important role
in mesangial hypercellularity and removal of deposits [39—411.
Then the possibility, that fibrin deposition is a cause of mesan-
gial hypercellularity through the stimulation of proliferation of
Ia-bearing cells and of migration of circulating monocytes,
remained unresolved. Although Nakashima et al found that the
platelet-derived growth factor stimulated mesangial cell prolif-
eration in culture [421 and Mulcion et al [431 and Wagner,
Lucas, and Nagle [44] reported the promoting effect of
macrophage products on the proliferation of cultured mesangial
cells, other factors, including immune complex or humoral
factors released from leukocytes have to be investigated.
Among the FDPs, the LMWFDP fraction 2 had a potent
cytotoxic effect on cultured mesangial cells. These results
suggest the biological significance of LMWFDP fraction 2 in
vivo in the development of the pathologic changes in the
glomerular lesions associated with accumulation or deposition
of fibrin and fibrinogen. Grond et al described that local
hemodynamic factors and deposition of circulating substances
such as lipids play a crucial role in the pathogenesis of focal
segmental glomerular sclerosis lesions [45]. Velosa et al [46]
found that in rats with focal sclerosis induced by
aminonucleoside of puromycin, irreversible epithelial cell dam-
age was the initiating event leading to a focal sclerosis and
fibrin-related antigen participated in the sclerotic process. All
these findings taken together indicate that the LMWFDP frac-
tion 2 inhibits the proliferation of mesangial cells and may
disrupt some functional activities, including disposal of depos-
its, thereby enhancing mesangial sclerosis.
On the other hand, degeneration and necrosis of mesangial
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Fig. 6. Effects of FDP-D, -E, and LMWFDP fraction 2 at the various concentration on 51Cr release from mesangial cells in culture. Each point
represents the mean SEM of six replicate wells.
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cells lead to mesangiolysis. Mesangiolysis plays a significant
role in experimental toxic glomerulopathies [47—49] and various
human glomerular lesions [50, 51]. The results of our studies
indicate that LMWFDP can be one of the causative agents of
necrosis of mesangial cells and mesangiolysis in vivo.
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